Shionogi & Co. Ltd. (SGIOY)
8.38
0.01 (0.12%)
At close: Apr 25, 2025, 3:51 PM
0.12% (1D)
| Bid | 8.35 |
| Market Cap | 14.26B |
| Revenue (ttm) | 423.36B |
| Net Income (ttm) | 150.1B |
| EPS (ttm) | 0.7 |
| PE Ratio (ttm) | 11.97 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 8.37 |
| Volume | 1,981 |
| Avg. Volume (20D) | 93,830 |
| Open | 8.72 |
| Previous Close | 8.37 |
| Day's Range | 8.31 - 8.38 |
| 52-Week Range | 6.22 - 8.62 |
| Beta | 0.15 |
About SGIOY
Shionogi & Co., Ltd. engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan. It offers Fetroja, a multidrug-resistant for gram-negative bacterial infection treatment; Xofluza, an influenza virus drug; and Tivicay for HIV treatment. It also develops Symproic for opioid-induced constipation treatment; S-120083 for Inflammatory pain; S-010887 for Neuropathic pain; S-1...
Sector Healthcare
IPO Date Dec 1, 2015
Employees 4,959
Stock Exchange PNK
Ticker Symbol SGIOY
Website https://www.shionogi.com
